Chad Gassert, SVP of Ani Pharmaceuticals ANIP, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $1.3M. The latest trade was on 02/28.

CG

CG

Chad Gassert

SVP - Corp. Dev. & Strategy

Company

Ani Pharmaceuticals ANIP

First filing

23/04/04

Trades

25 trades

Buys / sales

0 / 13

12-month net buying

−$1.3M

Last trade

02/28

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ani PharmaceuticalsANIP	Open-market sale	25/11/12–25/11/13	25/11/14	14,736 sh2 trades	$89.06avg.	$1,312,434.94	−8.5%
Ani PharmaceuticalsANIP	Open-market sale	25/08/15	25/08/18	20,000 sh	$86.97	$1,739,400	−10.4%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	24/07/01	24/07/02	20,000 sh	$63.44	$1,268,800	−9.4%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	24/06/03	24/06/04	20,000 sh	$64.41	$1,288,200	−8.6%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	24/05/01	24/05/03	20,000 sh	$66.62	$1,332,400	−7.9%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	24/04/01	24/04/02	20,000 sh	$67.25	$1,345,000	−7.3%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	24/03/11	24/03/13	20,000 sh	$65.81	$1,316,200	−6.8%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	23/10/02	23/10/03	20,000 sh	$56.48	$1,129,600	−6.4%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	23/09/01	23/09/05	20,000 sh	$64.70	$1,294,000	−6.0%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	23/08/01	23/08/03	20,000 sh	$51.06	$1,021,200	−5.7%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	23/07/03	23/07/06	20,000 sh	$53.43	$1,068,600	−5.4%
Ani PharmaceuticalsANIP	Open-market sale10b5-1 plan	23/06/22	23/06/23	20,000 sh	$51.32	$1,026,400	−5.1%